P/B
2,8
SS&C Technologies Holdings
SS&C Technologies provides software products and software-enabled services to a variety of customers primarily in financial services but also healthcare firms. Acquisitions are a large part of SS&C's history. SS&C GlobeOp provides fund administration services to alternative and traditional asset managers. In addition, SS&C provides portfolio accounting, portfolio management, trading, banking/lending, and other software to asset managers, banks, and financial advisors. SS&C’s purchase of Intralinks makes it a leading player in virtual deal room solutions. With its 2018 purchase of DST Systems, SS&C gained a foothold in the healthcare industry with pharmacy health management solutions and medical claim administration services. In 2022, SS&C completed the acquisition of Blue Prism.
SS&C Technologies provides software products and software-enabled services to a variety of customers primarily in financial services but also healthcare firms. Acquisitions are a large part of SS&C's history. SS&C GlobeOp provides fund administration services to alternative and traditional asset managers. In addition, SS&C provides portfolio accounting, portfolio management, trading, banking/lending, and other software to asset managers, banks, and financial advisors. SS&C’s purchase of Intralinks makes it a leading player in virtual deal room solutions. With its 2018 purchase of DST Systems, SS&C gained a foothold in the healthcare industry with pharmacy health management solutions and medical claim administration services. In 2022, SS&C completed the acquisition of Blue Prism.
$18.4B
Market Cap • 9/25/2026
2005
(21 years)
Founded
2010
(16 years ago)
IPO
NASDAQ
Listing Exchange
United States
Country
Valuation
P/S
2,8
P/EBITDA
8,1
P/OCF
10,2
P/FCF
10,5
P/E
22,6
BVPS
26,7
EPS
3,5
Market Cap
Market Cap
18,4B
EV
25,9B
EV/Revenue
3,9
EV/EBITDA
11,4
EV/EBIT
16,7
Payout
Dividend Per Share
1,1
Dividend Yield
1,4%
Buyback Yield
5,6%
Total Yield
7%
Dividend Yield 5Y
1,4%
Payout
30,2%
Retained Earnings
4,5B
Profitability
Gross Margin
48,1%
EBITDA Margin
34,6%
EBIT Margin
23,6%
Net Margin
13,2%
D&A/EBITDA
0%
R&D/Revenue
7,9%
Capex/Revenue
1%
Capex/D&A
9%
Capex/OCF
3,6%
SBC/OCF
14,8%
% PPE
2,3%
% Goodwill
48,2%
ROE
12,6%
ROIC
8,3%
Growth
CAGR Revenue 5Y
6,2%
CAGR Op. Income 5Y
6,9%
CAGR Net Income 5Y
3,7%
CAGR EPS 5Y
5,2%
CAGR OCF 5Y
8,8%
Leverage
N.D./EBITDA
3,2
Debt/Equity
0%
Current Ratio
1,1
Quick Ratio
0,3
Interest Coverage
355,1%
Premium
- Unrestricted access
- Unlimited data history
- Analysis videos
- Quarterly highlights
- Customizable financials table
- Ranking
- Discussions
...and much more!